Fulgent Genetics (FLGT) News Today $17.00 -0.62 (-3.52%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$16.88 -0.12 (-0.71%) As of 04:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Diametric Capital LP Acquires New Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)Diametric Capital LP bought a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 38,818 shares of the company's stock, valApril 2 at 6:19 AM | marketbeat.comCharles Schwab Investment Management Inc. Has $3.88 Million Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)Charles Schwab Investment Management Inc. reduced its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 14.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 210,211 shares of the comMarch 27, 2025 | marketbeat.com22,238 Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) Acquired by Proficio Capital Partners LLCProficio Capital Partners LLC bought a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 22,238 shares of the company's stockMarch 25, 2025 | marketbeat.comMagnetar Financial LLC Purchases Shares of 16,977 Fulgent Genetics, Inc. (NASDAQ:FLGT)Magnetar Financial LLC purchased a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 16,977 shares of the company's stock, valued at aMarch 24, 2025 | marketbeat.comIntech Investment Management LLC Increases Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)Intech Investment Management LLC boosted its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 248.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,539 shares of the company'sMarch 24, 2025 | marketbeat.comBank of New York Mellon Corp Sells 38,099 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)Bank of New York Mellon Corp cut its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 20.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 149,898 shares of tMarch 21, 2025 | marketbeat.comFulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A BuyMarch 20, 2025 | seekingalpha.comFulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 803.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 125,957 shares of the company's stockMarch 19, 2025 | marketbeat.comAlphaQuest LLC Acquires 27,085 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)AlphaQuest LLC increased its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 314.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,692 shares of the company's stMarch 12, 2025 | marketbeat.comProficio Capital Partners LLC Purchases New Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)Proficio Capital Partners LLC purchased a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 22,238 shares of the company's stock, valued at approximately $411,000. Proficio CapiMarch 11, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Sees Strong Trading Volume - Time to Buy?Fulgent Genetics (NASDAQ:FLGT) Sees Strong Trading Volume - What's Next?March 8, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Shares Gap Up on Insider Buying ActivityFulgent Genetics (NASDAQ:FLGT) Shares Gap Up on Insider Buying ActivityMarch 7, 2025 | marketbeat.comFulgent Genetics, Inc. (NASDAQ:FLGT) Sees Large Growth in Short InterestFulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the recipient of a large growth in short interest in February. As of February 15th, there was short interest totalling 1,300,000 shares, a growth of 23.8% from the January 31st total of 1,050,000 shares. Approximately 6.5% of the company's stock are sold short. Based on an average trading volume of 255,400 shares, the short-interest ratio is presently 5.1 days.March 7, 2025 | marketbeat.comFulgent Genetics, Inc. (FLGT) Stock ForecastsMarch 6, 2025 | ca.finance.yahoo.comFulgent Genetics (NASDAQ:FLGT) Raised to "Hold" at StockNews.comStockNews.com raised shares of Fulgent Genetics from a "sell" rating to a "hold" rating in a report on Wednesday.March 6, 2025 | marketbeat.comInsider Buying: Fulgent Genetics, Inc. (NASDAQ:FLGT) CFO Buys 100,000 Shares of StockFulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) CFO Paul Kim bought 100,000 shares of the business's stock in a transaction that occurred on Wednesday, March 5th. The shares were bought at an average cost of $15.96 per share, with a total value of $1,596,000.00. Following the completion of the purchase, the chief financial officer now directly owns 348,282 shares of the company's stock, valued at $5,558,580.72. This represents a 40.28 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.March 6, 2025 | marketbeat.comPaul Kim Acquires 100,000 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) StockMarch 6, 2025 | insidertrades.comPiper Sandler Has Lowered Expectations for Fulgent Genetics (NASDAQ:FLGT) Stock PricePiper Sandler lowered their price objective on Fulgent Genetics from $22.00 to $16.00 and set a "neutral" rating for the company in a research note on Tuesday.March 5, 2025 | marketbeat.comFulgent Genetics price target lowered to $16 from $22 at Piper SandlerMarch 4, 2025 | markets.businessinsider.comFulgent Genetics price target lowered to $20 from $27 at UBSMarch 2, 2025 | markets.businessinsider.comFulgent Genetics Full Year 2024 Earnings: EPS Beats ExpectationsMarch 1, 2025 | finance.yahoo.comFulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2024 Earnings Call TranscriptMarch 1, 2025 | insidermonkey.comFulgent Genetics (NASDAQ:FLGT) Updates FY 2025 Earnings GuidanceFulgent Genetics (NASDAQ:FLGT) updated its FY 2025 earnings guidance. The company provided EPS guidance of -0.650--0.650 for the period, compared to the consensus estimate of -0.460. The company also issued revenue guidance of $310.0 millionillion-$310.0 millionillion, compared to the consensus estimate of $324.2 millionillion.March 1, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Updates FY25 Earnings GuidanceFulgent Genetics (NASDAQ:FLGT) updated its FY25 earnings guidance. The company provided EPS guidance of $(0.65) for the period, compared to the consensus estimate of ($0.15). The company also issued revenue guidance of $310.0 millionillion, compared to the consensus estimate of $324.65 millionillion.March 1, 2025 | marketbeat.comQ4 2024 Fulgent Genetics Inc Earnings CallMarch 1, 2025 | finance.yahoo.comFulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call TranscriptFebruary 28, 2025 | seekingalpha.comFulgent Genetics reports Q4 EPS 4c, consensus (37c)February 28, 2025 | markets.businessinsider.comFulgent Genetics Revenue Tops EstimatesFebruary 28, 2025 | fool.comFulgent Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 28, 2025 | businesswire.comFulgent Genetics (FLGT) Expected to Announce Quarterly Earnings on FridayFulgent Genetics (NASDAQ:FLGT) will be releasing earnings before the market opens on Friday, February 28. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=663675)February 21, 2025 | marketbeat.comPeapod Lane Capital LLC Buys Shares of 109,459 Fulgent Genetics, Inc. (NASDAQ:FLGT)Peapod Lane Capital LLC purchased a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 109,459 shares of the company's stFebruary 13, 2025 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Reaches New 12-Month Low - Time to Sell?Fulgent Genetics (NASDAQ:FLGT) Sets New 1-Year Low - Here's WhyFebruary 11, 2025 | marketbeat.comFulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025February 6, 2025 | businesswire.comFulgent Genetics stock hits 52-week low at $16.32February 3, 2025 | msn.comFulgent Genetics (NASDAQ:FLGT) Reaches New 12-Month Low - Should You Sell?Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low - What's Next?February 3, 2025 | marketbeat.comFulgent Genetics stock hits 52-week low at $16.54January 23, 2025 | msn.comFulgent Genetics (NASDAQ:FLGT) Sets New 12-Month Low - Time to Sell?Fulgent Genetics (NASDAQ:FLGT) Reaches New 12-Month Low - Time to Sell?January 23, 2025 | marketbeat.comJPMorgan Chase & Co. Raises Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)JPMorgan Chase & Co. grew its position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 113.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 338,044 shares of the company's stock after buying an aJanuary 15, 2025 | marketbeat.comFulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Up 9.7% in DecemberFulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 821,300 shares, an increase of 9.7% from the November 30th total of 748,900 shares. Approximately 4.1% of the company's shares are short sold. Based on an average trading volume of 225,000 shares, the days-to-cover ratio is currently 3.7 days.December 31, 2024 | marketbeat.comFulgent Genetics: High Insider Ownership Supports Asymmetric UpsideDecember 24, 2024 | seekingalpha.comFulgent Genetics, Inc. (NASDAQ:FLGT) Shares Purchased by Barclays PLCBarclays PLC grew its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 22.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 174,855 shares of the company's stock after acquiring an additional 32,250 shares during the period. Barclays PDecember 23, 2024 | marketbeat.comWith 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backingDecember 21, 2024 | uk.finance.yahoo.comFulgent Genetics: A Value Stock With Caveats (Rating Downgrade)December 19, 2024 | seekingalpha.comShort Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Increases By 29.3%Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 748,900 shares, an increase of 29.3% from the November 15th total of 579,100 shares. Approximately 3.8% of the company's stock are sold short. Based on an average daily trading volume, of 203,600 shares, the short-interest ratio is currently 3.7 days.December 15, 2024 | marketbeat.comFulgent Genetics, Inc. (NASDAQ:FLGT) Shares Purchased by BNP Paribas Financial MarketsBNP Paribas Financial Markets lifted its position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 220.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,813 shares of the company's stock after acquiDecember 11, 2024 | marketbeat.comPoint72 Asset Management L.P. Purchases New Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT)Point72 Asset Management L.P. acquired a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The fund acquired 269,375 shares of the company's stock, valued at approximately $5,854,000. Point72December 9, 2024 | marketbeat.comJian Xie Sells 689 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) StockNovember 28, 2024 | insidertrades.comStockNews.com Downgrades Fulgent Genetics (NASDAQ:FLGT) to SellStockNews.com downgraded shares of Fulgent Genetics from a "hold" rating to a "sell" rating in a report on Wednesday.November 27, 2024 | marketbeat.comFulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right NowNovember 20, 2024 | msn.comFulgent Genetics (NASDAQ:FLGT) Sets New 12-Month Low - Here's WhyFulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low - Here's WhyNovember 19, 2024 | marketbeat.com Remove Ads Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address FLGT Media Mentions By Week FLGT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FLGT News Sentiment▼0.910.61▲Average Medical News Sentiment FLGT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FLGT Articles This Week▼22▲FLGT Articles Average Week Remove Ads Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARDT News Today PGNY News Today ADUS News Today AGL News Today PACS News Today AHCO News Today NHC News Today TDOC News Today VRDN News Today AVAH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FLGT) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FLGT Stock Free FLGT Stock Alerts